The First Clinical Study to Test Safety, Blood Levels and Other Effects of CDP6038 in Healthy Males

Clinical trial NCT01276119 · COMPLETED

Trial details

NCT number: NCT01276119
Sponsor: UCB Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics

Start date: 2008-09-01
Primary completion: 2009-10-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.